Patent directory · USPTO A61K / A61P
Patents matching “ras”
843 pharma patents match "ras" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 843 pharmaceutical patents matching "ras" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12390453
Method for reducing side effects from administration of phosphodiesterase-4 inhibitors
granted -
US 12391742
Anti-KRAS-G12D T cell receptors
granted -
US 12390512
Depolymerase capable of degrading extracellular polymeric substances of Klebsiella pneumoniae
granted -
WO 2025169901
CONJUGUÉ ANTICORPS-MÉDICAMENT CONTENANT UN COMPOSÉ HÉTÉROCYCLIQUE PRÉSENTANT UNE ACTIVITÉ D'INDUCTION DE LA DÉCOMPOSITION DE PROTÉINES MUTANTES KRAS
granted -
US 12384750
Ras inhibitors
granted -
US 12383652
Nanofiber structures and methods of manufacture and use thereof
granted -
US 12383503
Adagrasib solid pharmaceutical compositions
granted -
US 12383627
Antimicrobial scaffolds
granted -
WO 2025159142
COMPOSÉ HÉTÉROCYCLIQUE POUR INDUIRE LA DÉGRADATION DE LA PROTÉINE KRAS
granted -
US 12364685
Isoxazoline parasiticide formulations
granted -
US 12311016
Biomarkers and immunogenic compositions for filarial parasites
granted -
US 12310929
Use of rasagiline for the treatment of restless legs syndrome
granted -
US 12310944
Selective butyrylcholinesterase inhibitor or pharmaceutically acceptable salt thereof, preparation method and use thereof
granted -
US 12312391
Anti-mutated KRAS T cell receptors
granted -
US 12312334
Quinoxaline compounds and uses thereof
granted -
US 12304940
HLA class II-restricted t cell receptors against mutated RAS
granted -
US 12297447
Gene therapy for juvenile Batten disease
granted -
US 12291502
Topoisomerase II-alpha inhibitors and methods of treating cancer using the same
granted -
US 12286431
Crystalline forms of a KRas G12C inhibitor
granted -
US 12280113
Ras inhibitors
granted -
US 12281113
Crystalline forms of a KRas G12C inhibitor
granted -
US 12279630
Treatment and prevention of seed allergies
granted -
US 12263250
Nanofiber segments and methods of use thereof
granted -
US 12257306
Antiviral prodrugs and nanoformulations thereof
granted